Strategic partner UCHealth was among the investors in a round that took preventative healthcare company Catapult's total funding to more than $22m.

NantOmics provided the funding for Genos as it gets ready to commercially launch its exome sequencing service.

CVC units Brace Pharma Capital and MRL Ventures were among the investors as MiRagen took its total funding to $115m and agreed to acquire Signal Genetics.

NewYork-Presbyterian Hospital and HealthQuest Capital provided $6m to help the telehealth technology developer complete its series A round.

Stanford's StartX Fund has contributed to a series B round for UBiome, which will use the money to drive recruitment and conduct tests at its clinical lab.

Cell therapy developer Promethera Biosciences has raised $11m that will be inserted into an existing series C round featuring Mitsui, Boehringer Ingelheim and LifeLiver.

Unity Biotechnology, which raised $116m last week, is the fourth Arch Venture Partners-launched startup to be backed by WuXi PharmaTech.